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Abstract 
 
Comparative analysis of secretomes from 
deciduous and permanent periodontal ligament 
cells 
 
Kirim Kim 
 
Department of Dentistry 
The Graduate School, Yonsei University 
 
(Directed by Professor Je Seon Song) 
 
 
The aims of the present study were to identify and compare the secretomes of human 
deciduous and permanent periodontal ligament (PDL) cells.  
Secreted proteins were isolated and identified by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS). Antibodies against Tudor domain containing 7 (TDRD7) 
and Vasorin (VASN) were used for western blot. In addition, we used the cytokine 
 v 
membrane array analysis and enzyme-linked immunosorbent assay (ELISA) was 
performed for some cytokine (VEGF, EGF, PDGF-BB, SCF, and FGF beta).  
Collagen type VI, alpha I, collagen type I, alpha I, collagen type III, alpha I, cullin 7, 
and nuclear factor I/X (CCAAT-binding transcription factor) related to cell growth and/or 
maintenance were identified in deciduous PDL group. But vasorin (VASN), IGF binding 
protein 4, and S100 calcium binding protein A9 related to cell communication and signal 
transduction were identified in permanent PDL group. The secretomes that were 
upregulated in deciduous PDL tissues were involved in inflammatory or immune 
reactions (IL-1 alpha, IL-1 beta, IL-2, I-309, IL-12 p40/70, IL-4, MMP1).  
Proteins related to cell growth and/or maintenance, cell communication; signal 
transduction, inflammatory or immune reactions were slightly different between 
permanent PDL and deciduous PDL groups. These results show that humoral factors 
released from deciduous and permanent PDL cells have different characteristics.  
Although the findings in our study are not sufficient to explain difference between 
permanent and deciduous PDL clearly, our study provides clues to develop our 
understanding of the molecular basis. 
 
 
 
 
                                                                               
Keywords: secretome, cytokine, humoral factor, periodontal ligament cell, deciduous 
and permanent teeth
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I. INTRODUCTION 
 
Human have two dentitions, deciduous and permanent. The deciduous and permanent 
teeth exhibit distinctive developmental processes, morphologies, histological 
characteristics and life cycles. In addition, the proliferation activities and differentiation 
patterns differ between the cells isolated from the two types of teeth (Govindasamy et al., 
2010; Miura et al., 2003; Nakamura et al., 2009).  
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Since deciduous teeth are resorbed and exfoliated in association with the eruption of 
successive permanent teeth, the periodontal tissues of the former are more easily 
resorbed than those of the latter (Davies et al., 2001; Harokopakis-Hajishengallis, 2007). 
To explain this at the molecular level, some investigators reported that the periodontal 
tissues of deciduous teeth contain more bone sialoprotein and osteopontin with the Arg-
Gly-Asp (RGD) sequence, to which odontoclasts bind.(Bosshardt et al., 2005; Lee et al., 
2004) Others reported that periodontal ligament (PDL) cells obtained from areas being 
resorbed in deciduous teeth express more of the receptor activator of the nuclear factor κ-
light-chain-enhancer of activated B cells ligand (RANKL) gene, which is known to be 
associated with osteoclastogenesis.(Fukushima et al., 2003; Lossdorfer et al., 2002) In 
addition, extracellular-matrix-degrading enzymes such as collagenase (Alexander and 
Swerdloff, 1980), metalloproteinases (Linsuwanont et al., 2002; Wu et al., 1999), and 
mucopolysaccharidase (Alexander and Swerdloff, 1979) were found to be upregulated 
upon the resorption of deciduous periodontium. However, these findings are not 
sufficient to explain the differences in the periodontium of deciduous and permanent 
teeth. 
Besides, humoral factors of adjacent tissues have been focused recently as playing an 
important role in regulating grafted stem cells and characterizing differentiation process. 
Mesenchymal stem cells (MSCs) possess remarkable self-renewal ability and are able to 
differentiate into various cell lineages. MSCs can also enhance tissue repair and 
angiogenesis through a paracrine mechanism (Wang et al., 2011). In the experimental 
study, the results suggest that MSCs produce a broad repertoire of trophic factors with 
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tissue-regenerative activities (Ando et al., 2014). Previous study shows that PDL cells 
were also suggested to engage in differentiation and proliferation of adjacent tissues, 
such as MSCs (Mizuno et al., 2008) or the human alveolar bone–derived stromal cells 
(hABCs) (Park et al., 2012), by paracrine mechanism. However, in comparison with 
MSCs, the reports analyzing these humoral factors from PDL cells are insufficient. 
Especially, little is known about the secretomic signatures of deciduous PDL cells and 
the difference with that of permanent PDL cells. Identifying the key factors of various 
secretomes and their functions in secretome-mediated repair will contribute to the 
development of regenerative therapies. 
Considering these precious studies, it is a task of great significance to investigate the 
secretomes of two kinds of dentition, primary and permanent. The aims of the present 
study were to identify and compare the secretomes of human deciduous and permanent 
periodontal ligament in order to enhance our understanding of the molecular basis  
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II. Materials and Methods 
 
1. Cell Culture 
Permanent teeth periodontal ligament cells (P-PDL) were obtained from the permanent 
teeth (n=7 from 3males and 4 females, aged 7-18 years) and deciduous teeth periodontal 
ligament cells (D-PDL) were obtained from the deciduous teeth (n=7 from 3males and 4 
females, aged 2-11 years) under approved guidelines set by the Institutional Review 
Board of the Dental hospital, Yonsei University (approval no. 2-2014-0030). P-PDL and 
D-PDL cells were isolated by outgrowth (Song et al., 2012). Briefly, P-PDL and D-PDL 
tissue was cut into three fragments that were subsequently placed onto a 60-mm culture 
dish (BD Falcon, Lincoln Park, NJ, USA), and covered with a cover glass to allow the 
cells to grow out. P-PDL and D-PDL cells were cultured in a cell culture medium 
comprising alpha-minimum essential medium (α-MEM; Invitrogen, Carlsbad, CA, USA) 
containing 10% fetal bovine serum (FBS; Invitrogen), 100 U/ml penicillin, 100 µg/ml 
streptomycin (Invitrogen), and 2 mM L-glutamine (Invitrogen) at 37ºC in 5% CO2. The 
isolated P-PDL and D-PDL cells originated from at least two or three different donors 
were blended at passage 2, and cells at passages 3-5 were used for further experiments.  
 
2. Preparation of P-PDL and D-PDL-conditioned medium (P-PDL-CM and 
D-PDL-CM) 
PDL and DPDL cells were seeded at 3X105 cells on 100-mm culture dish (BD Falcon). 
When reaching 80% confluence, P-PDL and D-PDL cells were washed seven times with 
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PBS (pH 7.4; Invitrogen), and cultured in a cell culture medium descriebed above 
without FBS. After 48 hours, supernatant was collected and protease inhibitor cocktail 
(Roche Diagnostic Systems, Branchburg, NJ, USA) was added into supernatant. After 
filtration using an Amicon stirred cell (Merck Millipore, Darmstadt, Germany), 500 ml 
of harvested conditioned media (CM) were concentrated using Amicon ultra-15 
centrifugal filter unit with ultracel-3 membrane (nominal molecular weight limit 
(NMWL) 3kDa; Merck Millipore) and vivaspin®  500 centrifugal concentrator 
(molecular weight cut off (MWCO) 5000; Sartorius, Bohemia, NY, USA)  according to 
the manufacturer’s instructions. CM samples were dialyzed against PBS at 4ºC and used 
for further analysis. Protein concentration of CM was determined with the Bradford 
assay using the Bradford Dye Reagent (Bio-Rad, Hercules, CA, USA). 
 
3. Separation by one-dimensional polyacrylamide gel electrophoresis 
One-dimensional polyacrylamide gel electrophoresis (1DE) was performed using a 12% 
polyacrylamide gel. 12% polyacrylamide gel was prepared from 40% 
Acrylamide/BisTM (29:1) (Amresco, Solon, OH, USA), Sodium Dodecyl Sulfate (SDS) 
(Affymetrix, Santa Clara, CA, USA), Ammonium persulfate (APS) (Sigma-Aldrich, St 
Louis, MO, USA), Tris (Amresco), Glycine (Amresco), and N,N,N’,N’-
Tetramethylethylenediamine (TEMED) (Sigma-Aldrich, St Louis, MO, USA). Gels were 
run using a Mini-Protean Tetra cell system (Bio-Rad) and stained with Coomassie PRO 
solution (ProteomeTech Inc., Seoul, Korea). PageRuler Broad Range Unstained Protein 
Ladder (Thermo, Pittsburgh, PA, USA) was used for 1DE. After staining, gels were 
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washed with distilled water and scanned using ChemiDoc XRS+ (Bio-Rad). Gel images 
were processed using Image Lab software (Bio-Rad). Secreted protein sample lanes from 
CM were cut and processed using in-gel digestion procedures after polyacrylamide gel 
electrophoresis. 1DE was performed for three independent experiments. 
 
4. In-gel protein digestion  
Protein spots of interest were excised and digested in-gel with sequencing grade, 
modified trypsin (Promega, Madison, WI) as previously described.(Bahk et al., 2004) In 
brief, each protein spot was excised from the gel, placed in a polypropylene (Eppendorf, 
Hamburg, Germany) tube, and washed 4-5 times (until the gel was clear) with 150㎕ of 
1:1 acetonitrile (ACN)/25 mM ammonium bicarbonate (ABC), pH 7.8. The gel slices were 
dehydrated by 100% ACN, and then dried in a Speedvac concentrator. After reduction 
(incubation at 56°C for 45 minutes with 10 mM DTT in 100 mM ABC) and alkylation 
(incubation at room temperature for 30 minutes at dark place with 55 mM iodoacetamide 
in 100 mM ABC), the gel slices were dried by 100% ACN and the Speedvac. And then 
samples were rehydrated in 30㎕ of 25 mM ABC, containing 20 ng of trypsin. After 
incubation at 37℃ for 20 hours, the liquid was transferred to a new tube. Tryptic peptides 
remaining in the gel matrix were extracted for 40 minutes at 30℃ with 20㎕ of 50% (v/v) 
aqueous acetonitrile containing 0.1% (v/v) formic acid. The combined supernatants were 
evaporated in the Speedvac and dissolved in 8㎕ of 5 % (v/v) aqueous acetonitrile solution 
containing 0.1% (v/v) formic acid for mass spectrometric analysis.  
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5. Identification of proteins by liquid chromatography-coupled electrospray 
ionization mass spectrometry 
The resulting tryptic peptides were separated and analyzed using reversed phase 
capillary HPLC directly coupled to a Finnigan LCQ ion-trap mass spectrometer (LC-
MS/MS) (Zuo et al, 2001, with a slight modification) (Zuo et al., 2001). Both of a 0.1 ⅹ 
20 mm trapping and a 0.075 ⅹ 130mm resolving column were packed with Vydac 
218MS low trifluoroactic acid C18 beads (5㎛ in size, 300Å in pore size; Vydac, 
Hesperia, CA, USA) and placed in-line. Following the peptides were bound to the 
trapping column for 10 min at with 5% (v/v) aqueous acetonitrile containing 0.1% (v/v) 
formic acid, then the bound peptides were eluted with a 50 minutes gradient of 5– 80% 
(v/v) acetonitrile containing 0.1% (v/v) formic acid at a flow rate of 0.2 μl/min. For 
tandem mass spectrometry, a full mass scan range mode was m/z = 450– 2000Da. After 
determination of the charge states of an ion on zoom scans, product ion spectra were 
acquired in MS/MS mode with relative collision energy of 55%.  
The individual spectra from MS/MS were processed using the TurboSEQUEST software 
(Thermo Quest, San Jose, CA). The generated peak list files were used to query either 
MSDB database or NCBI using the MASCOT program (http://www.matrixscience.com). 
Modifications of methionine and cysteine (Carbamidomethyl (C), Deamidated (NQ), 
Oxidation (M)), peptide mass tolerance at 2 Da, MS/MS ion mass tolerance at 1 Da, 
allowance of missed cleavage at 1, and charge states (+1, +2, and +3) were taken into 
account. Only significant hits as defined by MASCOT probability analysis were 
considered initially. LC-MS/MS data were obtained for three independent experiments 
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and data were accumulated from three independent experiments. P-PDL and D-PDL 
secreted proteins with individual ion scores more than 20 (cut-off level was 20) were 
listed in table 1 and table 2. 
 
6. Western blot Analysis 
A protein amount of 20 μg from each sample was used for western blot analysis. 1DE 
was performed using a 8% polyacrylamide gel. Gels were run using a Mini-Protean Tetra 
cell system (Bio-Rad). Xpert 2 prestained protein marker (GenDEPOT, Barker, TX, USA) 
was used for Western blot After 1DE, blots were transferred to nitrocellulose membranes 
using TE77 ECL SemiDry Transfer Unit (Amersham biosciences, Piscataway, NJ, USA). 
Membranes were stained with Ponceau S (Siama-Aldrich) to verify loading equivalency. 
Membranes were incubated with antibodies against tudor domain-containing protein 7 
(TDRD7) diluted 1:5000 (rabbit polyclonal antibody; Ab103866, Abcam, Cambridge, 
UK) and vasorin (VASN) diluted 1:5000 (rabbit polyclonal, SLITL2; Ab156868, Abcam) 
followed by horseradish peroxidase-conjugated goat anti-rabbit IgG diluted 1:3000 
(#AP307P, Merck Millipore). Blots were developed with ECL (Pierce, Rockford, IL, 
USA) and visualized by using ChemiDoc XRS+ (Bio-Rad). Western blot data were 
obtained for three independent experiments. 
 
7. Cytokine Profiles of PDL-CM and DPDL-CM and Data Analysis 
Conditioned medium of PDL and DPDL (48 hours of culture) were analyzed using 
human cytokine array C5 (RayBiotech, Inc., Norcross, GA, USA), according to the 
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manufacturer’s instruction, as described in 2008 by Ohshima et al (Ohshima et al., 2008). 
A pair of cytokine array membranes were blocked with blocking buffer for 30 minutes 
and then incubated with 2ml of each conditioned medium at room temperature for 4hours. 
After samples were decanted from the container, the membranes were washed with wash 
buffer I three times and wash buffer II twice at room temperature with gentle shaking. 
Then membranes were incubated with diluted primary antibodies at 4ºC overnight and 
washed as described above. Membranes were incubated with horseradish peroxidase-
conjugated streptavidin for 30 minutes at room temperature. After washing, membranes 
were incubated with a peroxidase substrate for 5 minutes at room temperature. Finally, 
membranes were exposed to x-ray film (Hyper film ECL) for 5 to 15 minutes at room 
temperature. Three independent samples of PDL –CM and DPDL-CM were analyzed. 
Alpha MEM containing 0.1% FBS was used for positive control and alpha MEM without 
FBS was used for negative control. The images on x-ray films were captured by an 
optical scanner and saved as jpeg images. The signal intensities were quantified with 
image software (Gel quant pro, DNR Bio-Imaging Systems Ltd., Jerusalem, Israel) to 
compare intensities of the same cytokine from different samples. To prepare for 
normalization of the results, the measured v7alues of each cytokine (duplicate spots) on 
the same membrane were revised by subtracting the average of negative control spot 
values from the intensity of each spot, including positive control spot. Using these 
revised values, a percentage of the value of a cytokine spot versus the average of the 
positive control spot value on the same membrane was calculated as the relative 
expression lever (REL) of the cytokines as described in 2008 by Ohshima et al (Ohshima 
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et al., 2008). : REL (%) = (signal intensity of sample – mean intensity of negative control) 
× 100 (%)/(mean intensity of positive control – mean intensity of negative control). 
 
8. Enzyme-linked immunosorbent assay 
Enzyme-linked immunosorbent assay (ELISA) assay was performed using human 
growth factor ELISA strip II according to the manufacturer’s instructions. In brief, 8-
strip coated with different antibodies was incubated with PDL-CM and DPDL-CM for 1 
hour at room temperature with gentle shaking. After the CM samples were decanted from 
the 8-strip, and 8-strip was washed with assay buffer three times. Then samples were 
incubated with diluted biotin-labeled antibody mixture for 1 hour at room temperature 
with gentle shaking and washed with assay buffer three times. After washing, 8-strip was 
incubated with diluted streptavidin-HRP conjugate for 45 minutes at room temperature 
with gentle shaking and washed with assay buffer three times. And, 8-strip was 
incubated with substrate for 5 to 30 minutes at room temperature. After incubating, stop 
solution was added and measured the absorbance at 450 nm within 30 minutes using a 
spectrophotometer (Benchmark Plus microplate spectrophotometer, Bio-Rad). ELISA 
data were obtained from three independent experiments. 
 
9. Statistical Analysis 
All experiments were performed in triplicate. The normality of the data was evaluated 
using the Shapiro-Wilk test (p<0.05). The Mann-Whitney U test (p<0.05) was performed 
for all experiments using SPSS software (20.0 SPSS, Chicago, IL, USA) 
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III. Results 
 
1. 1DE and LC-MS/MS analysis of human P-PDL and D-PDL secreted 
protein 
1DE analysis was used to compare different protein band size between P-PDL and D-
PDL. The band pattern was nearly similar with slightly different size and wideness (Fig. 
1A). These bands were cut and trypsinized and used for LC-MS/MS analysis. The results 
of LC-MS/MS analysis indicated that 112 proteins were identified in P-PDL, 23 proteins 
were identified in D-PDL, and 17 proteins were identified in both samples (Fig 1B). P-
PDL and D-PDL secreted proteins with individual ion scores more than 20 and number 
of repetition more than 2 were listed in tables 1 and 2. To translate the data into a more 
meaningful biological context and to characterize more thoroughly the sets of 
functionally related proteins, the differentially identified data sets were organized into 
molecular function and biological process terms (Figure 2 and Table 1-3). Fig 2A shows 
molecular function analysis of P-PDL and D-PDL and Fig 2B shows biological process 
analysis of P-PDL and D-PDL. Proteins related to cell growth and/or maintenance, cell 
communication; signal transduction were slightly different between P-PDL and D-PDL. 
Collagen type VI, alpha I, collagen type I, alpha I, collagen type III, alpha I, cullin 7, and 
nuclear factor I/X (CCAAT-binding transcription factor) related to cell growth and/or 
maintenance were identified in D-PDL (Table 2, cullin 7 and nuclear factor I/X (CCAAT-
binding transcription factor) that number of repetition was 1 were not shown in table 2.). 
But vasorin (VASN), IGF binding protein 4, and S100 calcium binding protein A9 
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related to cell communication; signal transduction were identified in P-PDL (Table 1). 
Proteins related with catalytic activity indicated similar proportions in P-PDL and D-
PDL but percentage of enzyme inhibitor activity protein was slightly higher in P-PDL 
than D-PDL. Tudor domain containing 7, catalytic activity protein, was identified in D-
PDL, and cathepsin B and glucose-6-phosphate isomerase, catalytic activity protein, 
were identified in P-PDL (Tables 1-2). Plasminogen activator inhibitor, follistatin like 1, 
and alpha2-HS-glycoprotein related with enzyme inhibitor activity were identified in P-
PDL (Table 1). Transporter activity proteins such as lactotransferrin were identified in P-
PDL (Table 1). 
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Figure 1. 1DE and LC-MS/MS analysis of human permanent teeth periodontal ligament 
cell (P-PDL) and human deciduous teeth periodontal ligament cell (D-PDL) secreted 
protein. (A) P-PDL and D-PDL secreted protein were separated by SDS PAGE and 
stained with Coomassie blue dye. (B) Venn diagram of overlapping proteins of P-PDL 
and D-PDL and the number of individual proteins identified with liquid chromatography-
coupled electrospray ionization mass spectrometry (LC-MS/MS) analysis. 
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Figure 2. Molecular function and biological process analysis of LC-MS/MS. (A) 
Molecular function analysis of P-PDL and D-PDL. Molecular function was identified 
with 12 categories. (B) Biological process analysis of P-PDL and D-PDL. Biological 
process was analyzed with 11 categories. Molecular function and biological process term 
were represented as different color wedges in the pie charts, with the number of proteins 
per group shown in the pie charts. 
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Table 1. List of P-PDL secreted proteins in LC-MS/MS analysis. Proteins with individual 
ion score more than 20 and number of repetition more than 2 were listed. 
 
Protein name 
NCBI 
BLAST 
Scor
e 
Mass 
Number 
of 
repetitio
n 
Molecular 
function 
Biological 
process 
Collagen type VI, 
alpha 1 
gi|8719633
9 
3892 
10846
2 
3 
Extracellular 
matrix structural 
constituent 
Cell growth and/or 
maintenance 
Collagen type I, 
alpha 2 
gi|30102 2206 41496 3 
Extracellular 
matrix structural 
constituent 
Cell growth and/or 
maintenance 
Osteonection gi|2624793 1292 27054 2 
Calcium ion 
binding 
Cell growth and/or 
maintenance 
Collagen type I, 
alpha 1 
gi|180392 1205 98495 3 
Extracellular 
matrix structural 
constituent 
Cell growth and/or 
maintenance 
Quiescin Q6 
sulfhydryl oxidase 
1 
gi|1332507
5 
1045 82526 3 
Thiol oxidase 
activity  
Regulation of cell 
cycle 
Lumican gi|642534 846 38375 3 
Extracellular 
matrix structural 
constituent 
Cell growth and/or 
maintenance 
Tissue inhibitor of 
metalloproteinase 
1 
gi|31189 753 23182 2 
Extracellular 
matrix structural 
constituent 
Cell growth and/or 
maintenance 
Matrix 
metalloprotease 2 
gi|180671 581 72196 2 
Metallopeptidase 
activity 
Protein metabolism 
IGF binding 
protein 7 
gi|2210455
52 
461 28769 2 
Cell adhesion 
molecule activity 
Cell 
communication ; 
Signal transduction 
Mac 2 binding 
protein 
gi|5031863 397 65289 3 
Extracellular 
matrix structural 
constituent 
Immune response 
Plasminogen 
activator inhibitor 
gi|189578 389 45045 2 
Protease inhibitor 
activity 
Protein metabolism 
Vasorin 
gi|1548933
9 
381 64139 3 Receptor activity 
Cell 
communication; 
signal transduction 
Albumin 
gi|1196260
83 
293 58614 3 
Extracellular 
matrix structural 
constituent 
Transport 
Extracellular 
matrix protein 1 
gi|1943793
12 
260 59925 2 
Extracellular 
matrix structural 
constituent  
Cell growth and/or 
maintenance  
Follistatin like 1 gi|5901956 241 34963 2 
Enzyme inhibitor 
activity 
Metabolism 
Keratin 10 gi|28317 237 59492 2 
Structural 
constituent of 
cytoskeleton 
Cell growth and/or 
maintenance 
Collagen type V, 
alpha 1 
gi|189520 194 
18349
9 
2 
Extracellular 
matrix structural 
Cell growth and/or 
maintenance 
 16 
constituent 
Cathepsin B gi|181192 180 37783 2 Catalytic activity Metabolism 
IGF binding 
protein 6 
gi|183894 149 25177 2 
Cell adhesion 
molecule activity 
Cell 
communication ; 
Signal transduction 
CD248 molecule, 
endosialin 
gi|9966885 135 80807 2 Receptor activity 
Biological process 
unknown 
Fibulin 1 
gi|2276180
0 
132 70531 2 
Extracellular 
matrix structural 
constituent 
Cell growth and/or 
maintenance 
IGF binding 
protein 4 
gi|695254 123 27923 2 Binding 
Cell 
communication; 
signal transduction 
Actin, beta gi|28336 91 41786 2 
Extracellular 
matrix structural 
constituent 
Cell growth and/or 
maintenance 
Collagen type VI, 
alpha 3 
gi|5574309
8 
82 
34345
7 
2 
Extracellular 
matrix structural 
constituent 
Cell growth and/or 
maintenance 
Complement 
component 1, s 
subcomponent 
gi|4502495 76 76635 2 
Complement 
activity 
Immune response 
S100 Calcium 
binding protein A9 
gi|4506773 72 13234 2 Binding 
Cell 
communication; 
signal transduction 
Lactotransferrin gi|34412 57 78029 2 Transporter activity Transport 
Keratin 16 gi|186685 55 50668 2 
Structural 
constituent of 
cytoskeleton 
Cell growth and/or 
maintenance 
Glucose-6-
phosphate 
isomerase 
gi|189238 54 63149 2 Catalytic activity Metabolism 
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Table 2. List of D-PDL secreted proteins in LC-MS/MS analysis. Proteins with 
individual ion score more than 20 and number of repetition more than 2 were listed 
 
.Protein name 
NCBI 
BLAST 
Scor
e 
Mass 
Number 
of 
repetitio
n 
Molecular 
function 
Biological process 
Matrix 
metalloprotease 2 
gi|5822007 125 70872 2 
Metallopeptidase 
activity 
Protein metabolism 
Collagen type I, 
alpha 1 
gi|1196150
36 
122 84688 3 
Extracellular 
matrix structural 
constituent 
Cell growth and/or 
maintenance 
Osteonection gi|2624793 99 27054 2 
Calcium ion 
binding 
Cell growth and/or 
maintenance 
- gi|225477 85 
24920
3 
2 
Molecular function 
unknown 
Biological process 
unkown 
Albumin gi|28592 80 69321 3 
Extracellular 
matrix structural 
constituent 
Transport 
Quiescin Q6 
sulfhydryl oxidase 
1 
gi|1203965 74 86341 2 
Thiol oxidase 
activity  
Regulation of cell 
cycle 
Collagen type VI, 
alpha 1 
gi|30032 55 28565 2 
Extracellular 
matrix structural 
constituent 
Cell growth and/or 
maintenance 
Tudor domain 
containing 7  
gi|1943780
12 
33 47478 3 Catalytic activity 
Regulation of Rab 
GTPase activity 
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2. Western blot analysis  
To confirm the expression of important proteins identified in LC-MS/MS analysis, 
western blot analysis was performed. Vasorin (VASN), cell communication; signal 
transduction protein, was identified in P-PDL and tudor domain containing 7 (TDRD7), 
catalytic activity, was identified in D-PDL. And two important proteins were differently 
expressed between P-PDL and D-PDL. TDRD7 expression was stronger in D-PDL than 
P-PDL, but VASN expression was stronger in P-PDL than D-PDL (Fig. 3). 
 
 
 
Figure 3. Protein expression using Western blot analysis. TDRD7 was expressed in D-
PDL than P-PDL and VASN was expressed in P-PDL than D-PDL. Molecular weight of 
TDRD7 is 124 kDa and that of VASN is 72 kDa. 
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3. Cytokine membrane array analysis 
To identify the cytokine or growth factor that was undetected in LC-MS/MS, we used 
the cytokine membrane array analysis. Expression ratio was shown in the number that D-
PDL divided into P-PDL (Table 3). Fractalkine, IL-1 beta, IL-2, TGF beta 3, I-309, FGF7, 
ENA-78, IL-12 p40/70, IL-4, IL-15, FGF6, IL-5, TGF beta 1, SDF-1, IL-1 alpha, G-CSF, 
and IL-16 were higher expressed in D-PDL than P-PDL. And IGFBP2, Eotaxin1, ANG, 
Flt-3 ligand, IGF-1, GRO alpha, MIP-3 alpha, and MDC expressions were higher in P-
PDL than D-PDL. But expression ratios were not significantly differences between two 
types of CM (Mann-Whitney U test). These cytokines were grouped with biological 
process terms to check the meaningful biological context. In biological process grouping, 
there was a similar pattern of cytokine and growth factors except immune response. 
Cytokines related with immune response, such as IL-1 beta, IL-2, I-309, IL-12 p40/70, 
and IL-4, were slightly more expressed in D-PDL than P-PDL (Fig. 4 and Table 3). 
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Figure 4. Biological process analysis of cytokine membrane array. Biological process 
was divided with 5 categories. Among these categories, cytokine expression related to 
immune response was slightly higher in D-PDL than P-PDL and the other categories 
were similar expressions of cytokines. Biological process terms were represented as 
different color wedges in the pie charts, with the number of cytokines per group shown in 
the pie charts. 
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Table 3. List of cytokines in cytokine membrane array 
Name of cytokine Biological Process P-PDL D-PDL D-PDL/P-PDL 
Fractalkine / CX3CL1 
Cell communication;  
Signal transduction 
0.00  3.36  - 
IL-1 beta Immune response  0.39  13.84  35.26 
IL-2 Immune response  0.30  9.93  32.86 
TGF beta 3 
Cell communication;  
Signal transduction 
0.08  1.28  17.08 
I-309 Immune response  1.33  14.69  11.04 
FGF7 
Cell communication;  
Signal transduction 
1.69  6.53  3.85 
ENA-78(CXCL5) 
Cell communication;  
Signal transduction 
0.63  2.21  3.50 
IL-12 p40/70 Immune response  0.90  2.79  3.11 
IL-4 Immune response  0.71  2.19  3.09 
IL-15 Immune response  1.76  4.81  2.74 
FGF6 
Cell communication;  
Signal transduction 
1.74  4.71  2.71 
IL-5 Immune response  0.67  1.75  2.60 
TGF beta 1 
Cell communication;  
Signal transduction 
1.69  4.35  2.58 
SDF-1(CXCL12) 
Cell communication;  
Signal transduction 
0.45  1.10  2.44 
IL-1 alpha Immune response  6.83  15.46  2.26 
G-CSF Immune response  0.55  1.15  2.08 
IL-16 / IL16 
Cell communication;  
Signal transduction 
6.67  13.64  2.04 
Eotaxin3 / CCL26 
Cell communication;  
Signal transduction 
1.32  2.54  1.92 
IL-3 Immune response  5.42  9.67  1.78 
SCF 
Cell communication;  
Signal transduction 
2.36  4.10  1.74 
PDGF-BB / PDGFB 
Cell communication;  
Signal transduction 
3.95  6.33  1.60 
IL-6 Immune response  22.41  30.18  1.35 
PLGF 
Cell communication;  
Signal transduction 
27.45  36.17  1.32 
MCP-4 
Cell communication;  
Signal transduction 
1.24  1.60  1.29 
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Table 3. (Continued) 
 
Name of cytokine Biological Process P-PDL D-PDL D-PDL/P-PDL 
TGF beta 2 
Cell communication;  
Signal transduction 
64.90  83.26  1.28 
VEGF / VEGFA 
Cell communication;  
Signal transduction 
5.36  6.74  1.26 
IGFBP4 
Cell communication;  
Signal transduction 
3.23  3.90  1.21 
FGF9 
Cell communication;  
Signal transduction 
5.52  6.66  1.21 
MIF 
Cell communication;  
Signal transduction 
5.67  6.81  1.20 
CCL23 
Cell communication;  
Signal transduction 
4.85  5.74  1.18 
THPO 
Cell communication;  
Signal transduction 
2.03  2.33  1.15 
MIG Immune response  0.34  0.38  1.14 
LEP / Leptin 
Cell communication;  
Signal transduction 
7.84  8.89  1.13 
MIP-1 beta Immune response 73.84  82.86  1.12 
BDNF Cell growth and/or maintenance  14.30  15.94  1.11 
OPN(SPP1) 
Cell communication;  
Signal transduction 
20.10  21.98  1.09 
TIMP-2 Biological_process unknown 45.07  49.01  1.09 
IFN gamma Immune response  0.45  0.47  1.05 
FGF4 
Cell communication;  
Signal transduction 
2.61  2.75  1.05 
OPG 
Cell communication;  
Signal transduction 
71.00  74.75  1.05 
TNF alpha 
Cell communication;  
Signal transduction 
9.27  9.49  1.02 
IL-8 Immune response  9.42  9.63  1.02 
IGFBP3 
Cell communication;  
Signal transduction 
18.82  18.91  1.01 
MCP-2 Immune response  3.35  3.36  1.00 
OSM Cell growth and/or maintenance  32.56  32.34  0.99 
LIF 
Cell communication;  
Signal transduction 
29.59  29.38  0.99 
M-CSF Immune response  20.77  20.56  0.99 
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Table 3. (Continued) 
 
Name of cytokine Biological Process P-PDL D-PDL D-PDL/P-PDL 
MIP-1 delta 
Chemosensory behavior ; Cytokine and 
chemokine mediated signaling pathway  
6.85  6.78  0.99 
IP-10 / CXCL10 
Cell communication;  
Signal transduction 
38.75  37.82  0.98 
PARC 
Cell communication;  
Signal transduction 
6.24  6.07  0.97 
NT-4 
Cell communication;  
Signal transduction 
4.61  4.41  0.96 
TIMP-1 
Cell communication;  
Signal transduction 
57.82  54.44  0.94 
RANTES Immune response 28.66  26.92  0.94 
IGFBP1 
Cell communication;  
Signal transduction 
14.63  13.65  0.93 
IL-13 Immune response  1.83  1.70  0.93 
BLC / CXCL13 
Cell communication;  
Signal transduction 
2.43  2.19  0.90 
LIGHT / TNFSF14 Apoptosis ; Signal transduction 5.99  5.34  0.89 
HGF 
Cell communication;  
Signal transduction 
29.19  25.54  0.88 
NAP-2 
Cell communication;  
Signal transduction 
39.83  34.71  0.87 
GDNF 
Cell communication;  
Signal transduction 
32.40  28.16  0.87 
GM-CSF Immune response  1.51  1.31  0.87 
Eotaxin2 / CCL24 
Cell communication;  
Signal transduction 
15.14  13.08  0.86 
MCP-1 Immune response  77.91  67.31  0.86 
TNF beta 
Cell proliferation ; Cell differentiation ; 
Signal transduction ; Hemopoiesis  
15.24  13.15  0.86 
IL-10 Immune response  24.94  21.31  0.85 
NT-3 
Cell communication;  
Signal transduction 
11.70  9.74  0.83 
TARC Immune response 20.33  15.39  0.76 
MCP-3 
Cell communication;  
Signal transduction 
1.77  1.21  0.69 
EGF 
Cell communication;  
Signal transduction 
4.56  3.06  0.67 
IL-7 Immune response  1.53  0.88  0.57 
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Table 3. (Continued) 
 
Name of cytokine Biological Process P-PDL D-PDL D-PDL/P-PDL 
GCP-2 / CXCL6 Immune response 4.49  2.54  0.57 
GRO 
Regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolism  
10.78  5.86  0.54 
IGFBP2 
Cell communication;  
Signal transduction 
13.88  6.24  0.45 
Eotaxin1 / CCL11 
Cell communication;  
Signal transduction 
3.30  1.27  0.39 
ANG Cell growth and/or maintenance  34.42  13.06  0.38 
Flt-3 Ligand / FLT3LG 
Cell communication;  
Signal transduction 
3.12  1.15  0.37 
IGF-1 
Cell communication;  
Signal transduction 
3.31  1.04  0.31 
GRO alpha Immune response  4.22  1.11  0.26 
MIP-3 alpha Immune response  3.18  0.47  0.15 
MDC 
Cell communication;  
Signal transduction 
8.04  1.06  0.13 
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4. ELISA analysis 
To validate the cytokine membrane array, we used ELISA for some cytokine; VEGF, 
EGF, PDGF-BB, SCF, and FGF beta. In cytokine membrane array results, expression of 
VEGF was slightly higher in D-PDL and the other cytokine expressions were similar 
between two types of CM (Fig. 5). But there were not significantly differences between 
P-PDL and D-PDL (Mann Whitney U test). 
 
Figure 5. Validation of cytokine expression by ELISA. VEGF, EGF, PDGF-BB, and FGF 
were used for ELISA. Data were obtained from three independent experiments and the 
data are mean and standard deviation values. The optical densities of each cytokines did 
not differ significantly between P-PDL and D-PDL (Mann-Whitney U test) 
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IV. DISCUSSION 
 
Serum-free conditioned medium (CM) derived from PDL cells was analyzed to 
investigate the secretomes and our observations demonstrated that a variety of active 
soluble factors are secreted by PDL cells. There were several remarkable differences 
between human deciduous and permanent PDL groups 
In the present study, the secretomes that were upregulated in deciduous PDL tissues 
were involved in inflammatory or immune reactions leading to tissue degradation, 
extracellular-matrix-degrading enzymes. Interleukin 1, alpha (IL-1a) is involved in the 
immune response, inflammatory processes, and apoptosis (Nesic et al., 2001; Parker et 
al., 1989), and can enhance the biosynthesis of prostaglandin (Romero et al., 1989) and 
some kinds of MMPs (Shi et al., 2004). In addition, it up-regulates RANKL and down-
regulates OPG in PDL cells (Fukushima et al., 2005), and positively affects the survival 
and differentiation of osteoclasts or odontoclasts and consecutive bone or tooth 
resorption (Lee et al., 2002; Tani-Ishii et al., 1999; Zhang et al., 2003). IL-1b stimulates 
collagenase production in the periodontal ligament and induces connective tissue 
degradation in periodontitis (Ohshima et al., 1994; Ohshima et al., 1995). IL-2 is 
necessary for the growth, proliferation, and differentiation of thymic-derived 
lymphocytes (T cells) to become 'effector' T cells. IL-2 is normally produced by T cells 
during an immune response (Liao et al., 2011). Stromal cell-derived factor 1 (SDF-1) are 
small cytokines that belong to the chemokine family and strongly chemotactic for 
lymphocytes (De La Luz Sierra et al., 2004). Matrix metalloproteinase (MMP) is 
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associated with turnover of PDL matix and differentiation of osteoclast (Kanzaki et al., 
2001; Takahashi et al., 2003). In the previous study by Wu et al., compared with PDL 
cells from the permanent dentition, primary PDL cells generally produced a greater 
amount of collagenase but similar amounts of the inhibitor of matrix metalloproteinase 
(TIMP) (Wu et al., 1999). It is similar to our results. In LC-MS/MS analysis of this 
present study, whereas TIMP-1 was identified in both groups, P-PDL and D-PDL, 
MMP1 was identified only in D-PDL group. In consideration of the above, deciduous 
PDL tissues appear to be prone to resorption because of the relatively strong expressions 
of secretomes associated with tissue destruction. 
In addition, LC-MS/MS results of the present study showed that Tudor domain 
containing 7 (TDRD-7) was identified only in D-PDL and western blot analysis coinciding 
these results showed that TDRD-7 expression was stronger in D-PDL than P-PDL. In the 
previous study, Tiejun Zhang et al. showed that PHF20, tudor domaincontaining protein, 
promotes NF-κB transcriptional activity (Zhang et al., 2013). NF-κB is a member of a 
family of transcription factors that control the expression of critical genes that regulate 
immune responses (Ghosh and Hayden, 2008; Pasparakis, 2009; Vallabhapurapu and Karin, 
2009). Furthermore, NF-κB is involved in osteoclast and possibly in odontoclast formation 
(Wise et al., 2002). These findings give rise to the possibility that tudor domaincontaining 
protein functions as a positive effector in especially primary dentition that causes 
constitutive NF-κB activation, as in the context of physiologic or pathological conditions 
such as inflammation-linked root resorption. However, these findings are not sufficient and 
their precise functions in periodontal tissues remain to be elucidated.  
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In our present study, the secretomes involved in cell growth and/or maintenance were 
also upregulated in deciduous PDL tissues, and this finding concurs with the above 
previous studies. It was reported that the PDL cells from deciduous teeth also have a 
higher proliferation rate (Ji et al., 2013; Silverio et al., 2010). The results of cytokine 
membrane array showed that fibroblast growth factor (FGF) 6, 7 were expressed stronger 
in D-PDL than P-PDL. FGF family members are involved in a variety of biological 
processes, including embryonic development, cell growth, morphogenesis, tissue repair 
(Zhang et al., 2006). Especially, FGF-6 may be considered a regulator of bone 
metabolism as shown by its activity on both osteoblasts and osteoclasts (Bosetti et al., 
2010). Further investigation is required to determine their precise functions in 
periodontal tissues. 
The secretomes that were upregulated in permanent PDL tissues were involved in cell 
communication such as Vasorin (VASN) and Decorin, Insulin-like growth factor 1 (IGF-
1), Macrophage-derived chemokine (MDC). Particularly, LC-MS/MS results showed that 
Vasorin and Decorin were identified only in P-PDL and western blot analysis coinciding 
these results showed that Vasorin expression was stronger in P-PDL than D-PDL. 
Vasorin is a typical type I membrane protein, containing tandem arrays of a characteristic 
leucine-rich repeat motif, an epidermal growth factor-like motif, and a fibronectin type 
III-like motif at the extracellular domain (Klein et al., 1996; Tashiro et al., 1993). 
Decorin was found to share a significant homology with vasorin and interact directly 
with transforming growth factor-b (TGF-b) (Iozzo, 1999; Yamaguchi et al., 1990). In the 
previous study, Yuichi Ikeda et al. showed that that vasorin directly binds to TGF-b and 
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negatively modulates TGF-b (Ikeda et al., 2004). It was reported that TGF-b1 plays an 
important role as promoting osteoclastogenesis by enhancing the expression of genes 
such as MCP-1, CSF-1, IL-1a (Que and Wise, 1998; Wise, 2009; Wise and Lin, 1994). 
Considering the functional role of TGF-b in these studies, it is reasonably assumed that 
up-regulating of vasorin in permanent PDL tissue significantly inhibits resorption. 
Further investigations will be needed to clarify these issues. Insulin-like growth factor 1 
(IGF-1) was upregulated in permanent PDL tissues. IGF-1 is a hormone similar in 
molecular structure to insulin. IGF-1 stimulates systemic body growth, and has growth-
promoting effects on almost every cell in the body. In addition to the insulin-like effects, 
IGF-1 can also regulate cell growth and development (Zhang et al., 2008). MDC was also 
upregulated in permanent PDL tissues. MDC, also named C-C motif chemokine 22 (CCL22), 
may play a role in the trafficking of activated/effector T-lymphocytes to inflammatory sites and 
chemotactic for monocytes, dendritic cells and natural killer cells (Cronshaw et al., 2004). 
Angiogenin (ANG) were also upregulated in permanent PDL tissues. ANG is a key 
protein implicated in angiogenesis and interacts with endothelial and smooth muscle 
cells resulting in cell migration, invasion, proliferation and formation of tubular 
structures (Gao and Xu, 2008). The precise function of these cytokines in PDL tissues is 
in need of clarification. 
Osteoprotegerin (OPG) is a secreted glycoprotein that is a member of the tumor 
necrosis factor (TNF) receptor superfamily (Simonet et al., 1997; Tsuda et al., 1997; 
Yasuda et al., 1998). It appears that OPG is a receptor for RANKL and that its binding to 
RANKL inhibits cell-to-cell signaling between stromal cells and osteoclast precursors, 
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such that osteoclasts are not formed (Yasuda et al., 1998; Yasuda et al., 1999). 
Fukushima et al. reported that PDL cells from deciduous teeth or permanent teeth, were 
found to express OPG and not RANKL cells under non-resorbing conditions. On the 
contrary, human PDL cells around the roots of resorbing decidous teeth express enhanced 
levels of RANKL and as a results, ratio of RANKL/OPG was changed (Fukushima et al., 
2003). The present study showed that OPG was similar expression in P-PDL and D-PDL 
in cytokine membrane array analysis and concurred with the previous report. Monocyte 
chemoattractant protein-1 (MCP-1) was also similar expression in P-PDL and D-PDL in 
cytokine membrane array analysis. This factor was known to be major player in the pro-
inflammatory immune responses. Especially, MCP-1 is prime candidate for recruiting the 
osteoclast precursors (mononuclear cells) into the dental follicle (Wise et al., 2002). The 
previous study reported that PDL cells play an important role in maintaining the 
homeostasis by dual regulation through RANKL stimulation and OPG inhibition 
(Kanzaki et al., 2001). Considering functions of OPG and MCP-1 in our study, PDL cells 
might also regulate osteoclastogenesis by opposing mechanisms and more research is 
needed. 
The results of our study showed that Granulocyte-macrophage colony-stimulating 
factor (GM-CSF) and Glial cell-derived neurotrophic factor (GDNF) were detected 
similarly in P-PDL and D-PDL in cytokine membrane array analysis. GM-CSF was 
another inflammatory mediator and may be involved in the regulation of antigen-
presenting cells, especially dendritic cells, in the periodontium (Pastore et al., 1996). 
GDNF is neurotrophic factor believed to be involved in tooth morphogenesis (Nosrat et 
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al., 2002). GDNF and its receptors were reported to be related to the maturation of the 
periodontal Ruffini endings (Igarashi et al., 2007). 
Several of the expressed cytokines in our study, ANG, GDNF, IGFBP-2 and MCP-1 
were also found in previous study that investigate the cytokine profile of PDL fibroblasts 
(Ohshima et al., 2008). However, in contrast with our study, some cytokines, VEGF, 
GM-CSF, IL-6 and IL-8 were not detected in that study.  
On the other hand, human mesenchymal stem cells (hMSCs) are useful for 
regeneration of inflamed or injured tissues. In the previous study, the molecules 
identified in MSCs secretome clearly show the ability of MSCs not only to support 
hematopoiesis, but also supply autocrine/paracrine factors that influence angiogenesis, 
osteogenesis and chondrogenesis and immune regulation. Stem cell-based regenerative 
dentistry has emerged as a promising alternative for the current treatment options. With 
the clinically issues of treatment using stem-cell, cytokines also has emerged as the key 
factors regulating and characterizing stem cells. Compared the result of our study, there 
are comparatively small differences with the list of chemokines, cytokines and growth 
factors identified in the MSCs secretome (Skalnikova et al., 2011; Wang et al., 2011). In 
terms of chemokines, while IL-8, MCP-1, MIP-1 beta, MIP-3, ENA -78, GCP-2, IP-10, 
SDF-1 and PARC were identified in both the previous and our study, CCL5, CXCL1 and 
SDF-4 were identified only in the previous study. In terms of regulation of inflammation 
(pro-inflammatory or anti-inflammatory), while IL-1 alpha, IL-2, IL-4, IL-10, IL-12, IL-
13, IFN gamma, TNF alpha, TGF beta and MIF were identified in both studies, LMIF 
was identified only in the previous study. In terms of growh factors and growth factor-
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binding proteins, while G-CSF, M-CSF, GM-CSF, IGF-1, FGF-4, FGF-7, FGF-9, VEGF, 
HGF, SCF and IGFBP 1-6 were identified in both studies, PIGF, CTGF and IGFBP 7 
were identified only in the previous study. more studies are warranted to investigate the 
differences of secretome profile between MSCs and PDL cells. 
Although the findings in our study are not sufficient to explain difference between 
permanent and deciduous PDL clearly, this reports about differences of cytokine profiles 
between deciduous and permanent PDL tissues aids our understanding of histological 
and functional differences between them at the molecular level. 
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V. CONCLUSION 
 
Our study showed that humoral factors released from deciduous and permanent PDL 
cells have different characteristics. The secretomes that were upregulated in deciduous 
PDL tissues were involved in inflammatory or immune reactions, cell growth and/or 
maintenance. On the other hand, the secretomes that were upregulated in permanent PDL 
tissues were involved in cell communication. Because the investigated secretome types 
have not been well characterized, our conclusions are partially speculative. However, the 
main focus of this study was to identify and compare the cytokine profile of deciduous 
and permanent PDL. Each PDL groups showed the different cytokine profile, and there 
were some differences in respect of biological process and molecular function, too. 
Although the findings in our study are not sufficient to explain difference between 
permanent and deciduous PDL clearly, our study provides clues to develop effective 
therapeutic interventions for clinically challenging. 
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국문요약 
 
유치 및 영구치 치주인대세포에서 분비되는 
단백질체의 비교 분석 연구 
 
 
연세대학교 대학원 치의학과 
김 기 림 
지도교수: 송제선 
 
인간의 유치와 영구치는 다른 발달 과정, 형태학적 및 조직학적 특징, 생애 
주기를 보인다. 또한, 유치 및 영구치의 치주인대세포에서 분비되는 체액성 
인자들도 다른 특징을 보이는 듯 하다. 그럼에도 불구하고 이러한 차이에 대
한 기존의 연구는 거의 없는 편이다. 본 연구의 목적은 인간의 유치 및 영구
치 치주인대세포의 분비 단백질체를 확인하고 서로간에 비교하여 이에 대한 
분자수준의 이해도를 높이기 위함이다. 연구에 사용된 치주인대세포는 유치 
및 영구치에서 얻었으며, 여기서 분비된 단백질체를 별도로 분리시켰다. 이렇
게 분리된 분비단백질체를 LC-MS/MS 분석을 이용하여 알아보았으며, 그 결
과를 확인하고자 western blot 분석이 추가로 시행되었다. 더하여, LC-MS/MS 
에서 검출되지 못한 cytokine 또는 성장인자를 알아보기 위하여 cytokine 
 44 
membrane array 분석을 시행하였다. 이렇게 얻어진 결과 중 특정 cytokine은 
ELISA 분석을 통해 좀 더 면밀히 검증하였다. 이렇게 얻어진 cytokine들은 보
다 의미있는 분석을 위해 생물학적 과정 및 기능에 따라 몇 가지 그룹으로 
분류되었으며, 유치와 영구치간 비교에서 대체로 비슷한 양상을 보였으나 몇
몇 그룹은 주목할만한 차이가 있었다. 유치의 경우 염증과 면역 관련 및 세포 
성장과 유지에 관련된 분비단백질체가 높게 측정되었다. 반면에, 영구치의 경
우 세포 신호교신 및 신호 전달 과정과 연관된 분비단백질체가 높게 측정되
었다. 본 연구 결과는 유치와 영구치 치주인대세포의 체액성 인자 간에 차이
점을 보여주었으며, 나아가 비정상적 치근 흡수 치료 및 줄기세포를 이용한 
재생치의학을 다룸에 있어 유치와 영구치가 다른 작용 및 반응을 할 수 있음
을 제시한다. 
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